Summary
1,2,3,4-tetrahydro-2-methyl-4,6,7-isoquinolinetriol (TMIQ), a tetrahydroisoquinoline derivate of adrenaline, was tested for potency as an analog of the dopamine depleting agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in assays of tyrosine hydroxylase (TH) activity in the striatal synaptosome preparation. TMIQ inhibited TH activity with an IC50 (4 × 10−6M) similar to that found for MPTP (IC50 1 × 10−6M). TH inhibitions produced by IC50 concentrations of TMIQ were reversed by monoamine oxidase (MAO)-A or MAO-B inhibitors (clorgyline or deprenyl), or the dopamine reuptake blocker nomifensine, or excess cofactor (6R)-5,6,7,8-tetrahydro-L-biopterin. TMIQ did not appear to act at the presynaptic D2 sulpiride sensitive autoreceptor for dopamine synthesis modulation. Thesein vitro data are consistent with earlier findings that TMIQ acts as a dopamine depleting agent, and with the possibility that TMIQ may have a degree of MPTP-like activityin vivo.
Similar content being viewed by others
References
Abell CW, Shen R-S, Gessner W, Brossi A (1984) Inhibition of dihydropteridine reductase by novel 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropteridine analogs. Science 224: 405–407
Bates HA (1981) Pictet-Spengler reactions of epinephrine with formaldehyde and acetaldehyde. J Org Chem 46: 4931–4935
Birkmayer W, Birkmayer JGD, Vrecko K, Mlekush W, Paletta B, Ott E (1989) The coenzyme nicotinamide dinucleotide (NADH) improves the disability of Parkinsonian patients. J Neural Transm [P-D Sect] 1: 297–302
Brenneman AR, Kaufman S (1964) The role of tetrahydrobiopterin in the enzymatic conversion of tyrosine to 3, 4-dihydroxyphenylalanine. Biochem Biophys Res Commun 17: 177–183
Chiueh CC, Markey SP, Burns RS, Johannessen JN, Pert A, Kopin IJ (1984) Neurochemical and behavioural effects of systemic and intranigral administration of N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in the rat. Eur J Pharmacol 100: 189–194
DiMonte DA, Wu EY, Irwin I, Delanney LE, Langsten JW (1991) Biotransformation of 1-methyl-4-phenyl-1, 2, 3,6-tetrahydropyridine in primary cultures of mouse astrocytes. J Pharmacol Exp Ther 258: 594–599
El Mestikawy S, Glowinski J, Hamon M (1986) Presynaptic dopamine autoreceptors control tyrosine hydroxylase activation in depolarised striatal dopaminergic terminals. J Neurochem 46: 12–22
Heikkila RA, Hess A, Duvoisin RC (1984 a) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine in mice. Science 224: 1451–1453
Heikkila RA, Manzino L, Cabbat FS, Duvoisin RC (1984 b) Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311: 467–469
Hirata Y, Nagatsu T (1985 a) Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion. Neurosci Lett 57: 301–305
Hirata Y, Nagatsu T (1985 b) Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Brain Res 337: 193–196
Hirata Y, Togari A, Nagatsu T (1983) Studies on tyrosine hydroxylation system in rat brain slices using High Performance Liquid Chromatography with electrochemical detection. J Neurochem 40: 1585–1589
Hirata Y, Sugimura H, Takei H, Nagatsu T (1986) The effects of pyridinium salts structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+) on tyrosine hydroxylation in rat striatal tissue slices. Brain Res 397: 341–344
Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinson-inducing neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridinium by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82: 2173–2177
Kettler R, Bartholini G, Pletscher A (1974) In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin. Nature 249: 476–478
Levitt M, Spector S, Sjoerdsma A, Udenfriend S (1965) Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea pig heart. J Pharmacol Exp Ther 148: 1–8
Liptrot JL, Holdup D, Phillipson OT (1993) 1, 2, 3, 4-tetrahydro-2-methyl-4, 6, 7-isoquinolinetriol depletes catecholamines in rat brain. J Neurochem 61: 2199–2206
Lovenberg W, Levine RA, Robinson DS, Ebert M, Williams AC, Calne DB (1978) Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science 204: 624–626
Maret G, Tayar NE, Carrupt P-A, Testa B, Jenner P, Baird M (1990) Toxication of MPTP (1-methyl-4-phenyl-1, 2, 3, 6-tetrahyropyridine) and analogs by monoamine oxidase. Biochem Pharmacol 40: 783–792
Miwa S, Yasuyoshi W, Hayaishi O (1985) 6R-L-erythro-5, 6, 7, 8-tetrahydrobiopterin as a regulator of dopamine and serotonin biosynthesis in the rat brain. Arch Biochem Biophys 239: 234–241
Mogi M, Harada M, Kojima K, Kiuchi K, Nagatsu I, Nagatsu T (1987) Effects of repeated systemic administration of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activityin vitro and tyrosine hydroxylase content. Neurosci Lett 80: 213–218
Naoi M, Matsuura S, Parvez H, Takahashi T, Hirata Y, Minami M, Nagatsu T (1989) Oxidation of N-methyl-1, 2, 3, 4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase. J Neurochem 52: 653–655
Okuno S, Fujisawa H (1991) Conversion of tyrosine hydroxylase to stable and inactive forms by the end products. J Neurochem 57: 53–60
Ozaki N, Nakahara D, Mogi M, Harada M, Kiuchi K, Kaneda N, Miura Y, Kasahara Y, Nagatsu T (1988) Inactivation of tyrosine hydroxylase in rat striatum by 1-methyl-4-phenylpyridinium ion (MPP+). Neurosci Lett 85: 228–232
Pollock RJ, Kapatos G, Kaufman S (1981) Effect of cyclic AMP-dependent protein phosphorylating conditions on the pH-dependent activity of tyrosine hydroxylase from beef and rat striata. J Neurochem 37: 855–860
Roth RH (1984) CNS dopamine autoreceptors: distribution, pharmacology and function. Ann NY Acad Sci 430: 27–53
Saporito MS, Heikkila RE, Youngster SK, Nicklas WJ, Geller HM (1992) Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respiration. J Pharmacol Exp Ther 260: 1400–1409
Sayre LM, Wang F, Arora PK, Riachi NJ, Harik SI, Hoppel CL (1991) Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances. J Neurochem 57: 2106–2115
Singer TP, Salach JI, Castagnoli N, Trevor A (1986) Interactions of the neurotoxic amine 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine with monoamine oxidases. Biochem J 235: 785–789
Shen R, Smith RV, Davis PJ, Brubaker A, Abell CW (1982) Dopamine-derived tetrahydroisoquinolines-novel inhibitors of dihydropteridine reductase. J Biol Chem 257: 7294–7297
Togari A, Kano H, Oka K, Nagatsu T (1983) Simultaneous simple purification of tyrosine hydroxylase and dihydropteridine reductase. Anal Biochem 132: 183–189
Vrecko K, Birkmayer JGD, Krainz J (1993) Stimulation of dopamine biosynthesis in cultured PC 12 phaeochromocytoma cells by the coenzyme nicotinamide adeninedinucleotide (NADH). J Neural Transm [P-D Sect] 5: 147–156
Weiner N, Cloutier G, Bjur R, Pfeffer RI (1972) Modification of norepinephrine synthesis in intact tissue by drugs and during short term adrenergic nerve stimulation. Pharmacol Rev 24: 203–221
Youngster SK, Sonsalla PK, Sieber B-A, Heikkila RE (1989) Structure-activity study of the mechanism of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity. 1. Evaluation of biological activity of MPTP analogs. J Pharmacol Exp Ther 249: 820–828
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liptrot, J., Holdup, D. & Phillipson, O. 1,2,3,4-Tetrahydro-2-methyl-4,6,7-isoquinolinetriol inhibits tyrosine hydroxylase activity in rat striatal synaptosomes. J. Neural Transmission 96, 51–62 (1994). https://doi.org/10.1007/BF01277928
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01277928